ORCL enters the final stretch before its June 8 earnings with options buyers paying the most for downside protection in months — even as the analyst community just raised its most bullish targets of the year.
The clearest signal this week is in the options market. The put/call ratio has climbed to 0.91, running more than two and a half standard deviations above its 20-day average of 0.83 — the highest defensive reading of the past year outside of one brief spike last April. That's a meaningful shift. Two weeks ago, the PCR sat comfortably in the 0.82-0.84 range. The jump this week signals a material increase in demand for downside hedges, even as the stock is only 3% off its recent high.
The short interest picture tells a calmer story, and it has changed since last week's note. SI edged fractionally lower — down roughly 1% on the day — to 1.1% of the free float, and barely moved on a week-over-week basis. That's consistent with what was flagged in previous coverage: shorts were quietly rebuilding through May, but that trend appears to have plateaued. Borrow conditions remain entirely undemanding. Cost to borrow dropped sharply to 0.23% from 0.48% a week ago, and availability is vast at over 5,500% of short interest — meaning the lending pool is nowhere near stressed. For all the options nervousness, there's no evidence of a short-squeeze setup or any meaningful crowding in the borrow market.
The analyst picture remains notably constructive, even as the stock pulls back. Wedbush's $275 target, set May 13, and Oppenheimer's $235 lift from the same day are both still fresh — both firms citing AI infrastructure momentum that Oracle is capturing faster than consensus modelled. The bull case rests on solid ground: cloud revenue up 41% year-on-year, AI infrastructure demand accelerating at 243%, and remaining performance obligations surging 325%. Management has guided FY27 revenue to $90 billion — an ambitious number that the Street is increasingly willing to credit. Morgan Stanley is the visible holdout, sitting at Equal-Weight with a $207 target, just above the current $181 close. The mean target of $244 implies roughly 34% upside from here — a gap that puts ORCL near the top of the software universe on analyst return potential. Valuation multiples have compressed modestly over the past week, with EV/EBITDA down about 0.45x and the P/B ratio off half a point — both drifting lower alongside the price pullback rather than re-rating on any fundamental development.
The peer divergence this week is worth noting. CRWD gained nearly 13% over the same period. RBRK added 6.4%. DDOG climbed 7.6%. Oracle, by contrast, lost 2.9% on the week — the weakest outcome in its immediate peer group, with only CDNS (down 5.6%) and QBTS (down 18.6%) faring worse. The underperformance looks more like sector rotation than any ORCL-specific deterioration: the names gaining are pure-play security and observability platforms where near-term catalysts are more visible. Oracle's next catalyst is three weeks out.
The March 10 earnings print — a 7.6% single-day gain — is the reference point the market is now pricing around. Whether the June 8 quarter can replicate that reaction depends on how cloud revenue tracks against the raised FY27 guidance and whether AI infrastructure bookings continue to accelerate. The widening gap between the defensive options positioning and the bullish analyst consensus is where the tension lives heading into that date.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
